Preclinical validation of anti‐nuclear factor‐kappa B therapy to inhibit human vestibular schwannoma growth
Crossref DOI link: https://doi.org/10.1016/j.molonc.2015.03.009
Published Online: 2015-03-31
Published Print: 2015-08
Update policy: https://doi.org/10.1002/crossmark_policy
Dilwali, Sonam
Briët, Martijn C.
Kao, Shyan-Yuan
Fujita, Takeshi
Landegger, Lukas D.
Platt, Michael P.
Stankovic, Konstantina M.
Version of Record valid from 2015-03-31
Publication History
Received: 2014-08-12
Accepted: 2015-03-23
Published: 2015-03-31